Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Haynes: B cell Lineage Envelope Design from RV144 Antibodies |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Characterization |
| Species: | Non-organism study |
| Stage: | Assays complete |
| Study Start Date: | 2015-11-14 |
| Study Made Public: | 2016-12-06 |
Title
RV305 mAbs Differ in Strength and Breadth from RV144 mAbs
Description
CAVD 532 is a monoclonal antibody screening study to evaluate V2-glycan binding in RV305 subjects.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Saline (non-specific) Placebo ALVAC Placebo AIDSVAX B/EIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.